ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
32.95
Today's Change
-0.05 (0.15%)
Day's Change
32.61 - 33.38
Trading Volume
440,272
Market Cap
19 Billion
Shares Outstanding
586 Million
Avg Volume
463,442
Avg Price (50 Days)
33.46
Avg Price (200 Days)
27.90
PE Ratio
164.75
EPS
0.20
Earnings Announcement
27-Nov-2024
Previous Close
33.00
Open
33.33
Day's Range
32.61 - 33.38
Year Range
19.79 - 35.76
Trading Volume
440,272
1 Day Change
-0.15%
5 Day Change
0.98%
1 Month Change
0.46%
3 Month Change
13.39%
6 Month Change
26.25%
Ytd Change
49.43%
1 Year Change
58.64%
3 Year Change
8.17%
5 Year Change
79.37%
10 Year Change
580.79%
Max Change
1255.97%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.